|
|
|
| Research progress of nutritional therapy for fatty liver |
| CHEN Qiao LI Ling LI Suyun |
| Department of Infectious Disease, Union Hospital Tongji Medical College Huazhong University of Science and Technology, Hubei Province, Wuhan 430022, China |
|
|
|
Abstract Fatty liver is a common clinical liver disease, which seriously affects life health of mankind. The imbalance of daily nutrition intake and the neglect of dietary nutrition management can lead to the excessive accumulation of fat and abnormal metabolic function in the liver, leading to fatty liver. Therefore, scientific nutrition management and dietary nutrition collocation can effectively prevent and treat fatty liver. In this paper, the pathogenesis of fatty liver was briefly introduced, and reasonable restriction of energy and dietary fat intake, control of saturated fatty acid intake, and appropriate increase of monounsaturated fatty acid intake were emphasize, which can effectively prevent and improve fatty liver. In addition, the reasonable collocation of nutritional supplements and scientific exercise management also have a positive impact on the prevention and treatment of fatty liver.
|
|
|
|
|
|
[1] 李娜，周艳，刘娟，等.肠道微生态失调对非酒精性脂肪肝影响的研究进展[J].成都医学院学报，2019，14（1）：133-136.
[2] Bannister DW. The biochemistry of fatty liver and kidney syndrome. Biotin-mediated restoration of hepatic gluconeogenesis in vitro and its relationship to pyruvate carboxylase activity [J]. Biochem J，2019，156（1）：167-173.
[3] Sayiner M，Arshad T，Golabi P，et al. Extrahepatic manifestations and healthcare expenditures of non-alcoholic fatty liver disease in the Medicare population [J]. Hepatol Int，2020，14（4）：556-566.
[4] 张松，夏卫.血糖和血脂异常与体检人群脂肪肝患病率和严重度的相关性[J].肝脏，2018，23（12）：96-98.
[5] 杨婧，高红，赵耀伟，等.肝窦内皮细胞在非酒精性脂肪性肝病发病过程中的作用[J].临床肝胆病杂志，2020，36（11）：2601-2604.
[6] Chen J，Xuan YH，Luo MX，et al. Kaempferol alleviates acute alcoholic liver injury in mice by regulating intestinal tight junction proteins and butyrate receptors and transporters [J]. Toxicology，2019，429：152338.
[7] Bazwinsky-Wutschke I，Zipprich A，Dehghani F. Endocannabinoid system in hepatic glucose metabolism，fatty liver disease，and cirrhosis [J]. Int J Mol sci，2019，20（10）：2516.
[8] Cassard AM，Ciocan D. Microbiota，a key player in alcoholic liver disease [J]. Clin Mol Hepatol，2018，24（2）：100-107.
[9] Tang L，Yang F，Fang Z，et al. Resveratrol ameliorates alcoholic fatty liver by inducing autophagy [J]. Am J Chin Med，2016，44（6）：1207-1220.
[10] 王政，葛冰洁，王萌，等.中药对酒精性肝损伤的保护作用研究进展[J].延边大学农学学报，2019，41（3）：102-108.
[11] 高婷，徐艳红，章小英，等.线粒体硫辛酸合成通路调节细胞能量代谢的机制[J].中国细胞生物学学报，2018， 40（10）：1767-1773.
[12] 胡晓娜，董方元，姜鑫，等.敲减心磷脂酰基转移酶1对肝细胞脂肪变和氧化应激的影响及其机制[J].中华消化杂志，2020，40（8）：546-554.
[13] 李园园，周俊英.脂素-1在酒精性脂肪肝发病机制中的作用[J].中华肝脏病杂志，2016，24（3）：237-240.
[14] 曾义岚，韩源平，王丽，等.维生素D缺乏与非酒精性脂肪性肝病的关系及机制[J].中国肝脏病杂志：电子版，2019，11（1）：12-16.
[15] Zhang CH，Zhou BG，Sheng JQ，et al. Molecular mechanisms of hepatic insulin resistance in nonalcoholic fatty liver disease and potential treatment strategies [J]. Pharmacol Res，2020，159：104984.
[16] Yki-Jrvinen H. Ceramides：A cause of insulin resistance in nonalcoholic fatty liver disease in both murine models and humans [J]. Hepatology，2020，71（4）：1499-1501.
[17] 赵梦鸽，杨慧敏，蒋翠花，等.青钱柳三萜化合物对游离脂肪酸诱导的脂肪变性的干预作用[J].中国药科大学学报：英文版，2018，49（3）：333-340.
[18] Khaleel EF，Abdelaleem GA，Mostafa DG. Resveratrol improves high-fat diet induced fatty liver and insulin resistance by concomitantly inhibiting proteolytic cleavage of sterol regulatory element-binding proteins，free fatty acid oxidation，and intestinal triglyceride absorption [J]. Can J Physiol Pharm，2018，96（2）：145-157.
[19] Satapati S，Kucejova B，Duarte JAG，et al. Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver [J]. J Clin Invest，2015，125（12）：4447-4462.
[20] 盛佳智，弓腊梅.热量限制的低碳水化合物饮食和膳食纤维对非酒精性脂肪肝影响的研究进展[J].食品工业科技，2020，446（6）：344-348.
[21] 房玲玲，李小燕，徐斌斌，等.轻断食与低能量均衡饮食对减重效果及代谢的影响比较[J].中华临床营养杂志，2019，27（5）：309-314.
[22] Shah K，Stufflebam A，Hilton TN，et al. Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults [J]. Obesity，2012，17（12）：2162-2168.
[23] Chen X，Li L，Liu X，et al. Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis [J]. Life Sci，2018，203：291-304.
[24] Grasselli E，Baldini F，Vecchione G，et al. Excess fructose and fatty acids trigger a model of nonalcoholic fatty liver disease progression in vitro：Protective effect of the flavonoid silybin [J]. Int J Mol Med，2019，44（2）：705-712.
[25] Chen LH，Wang YF，Xu QH，et al. Omega-3 fatty acids as a treatment for non-alcoholic fatty liver disease in children：A systematic review and meta-analysis of randomized controlled trials [J]. Clin Nutr，2018，37（2）：516-521.
[26] Rezaei S，Akhlaghi M，Sasani MR，et al. Olive oil improved fatty liver severity independent of cardiometabolic correction in patients with non-alcoholic fatty liver disease，a randomized clinical trial [J]. Nutrition，2019，57， 154-161.
[27] 李微，高强，马凌波.维生素E与熊去氧胆酸对非酒精性脂肪肝大鼠的协同肝保护机制[J].基因组学与应用生物学，2019，12：5713-5718.
[28] Vilar-Gomez E，Vuppalanchi R，Gawrieh S，et al. Vitamin E improves transplant-free survival and hepatic decompensation among patients with nonalcoholic steatohepatitis and advanced fibrosis [J]. Hepatology，2020，71（2）：495-509.
[29] Guo XF，Wang C，Yang T，et al. Vitamin D and non-alcoholic fatty liver disease：a meta-analysis of randomized controlled trials [J]. Food Funct，2020，11：7389-7399.
[30] Choi DH，Jung CH，Mok JO，et al. Nonalcoholic fattyliver disease and abdominal fat accumulation according to Vitamin D status in patients with type 2 diabetes [J]. J Obes Metab Syndr，2018，27（1）：53-60.
[31] 张玉波.三七脂肝丸联合多烯磷脂酰胆碱治疗脂肪肝的临床研究[J].现代药物与临床，2019，34（9）：2774-2777.
[32] 盛佳智，弓腊梅.热量限制的低碳水化合物饮食和膳食纤维对非酒精性脂肪肝影响的研究进展[J].食品工业科技，2020，446（6）：344-348.
[33] 谢佳，刘冬，朱成敏，等.膳食干预联合运动对超重肥胖大学生身体机能与素质的影响评价研究[J].粮油食品科技，2020，28（5）：190-193.
[34] 张洁，余红艳，邸阜生.高强度间歇运动对C57BL/6小鼠高脂饮食诱导肝脏脂肪沉积的影响[J].中华肝脏病杂志，2019，27（4）：312-315.
[35] O’Gorman P，Naimimohasses S，Monaghan A，et al. PS-105-Significant regression in fibrosis in paired liver biopsies following a 12-week aerobic exercise intervention in individuals with non-alcoholic fatty liver disease [J]. J Hepatol，2019，70（1）：e67.
[36] 荆文，李传芬，冯连世.运动激活AMPK改善非酒精性脂肪肝的研究进展[J].体育科学，2019，39（10）：91-97.
[37] 谷静，周扬.健康教育在脂肪肝患者护理中的应用[J].中国保健营养，2019，29（29）：221.
[38] 程晓慧.健康教育在脂肪肝患者护理中的应用[J].中国医药指南，2018，16（3）：292-293.
[39] 王珍茹，陈艳，王雪梅.PBL健康教育模式在非酒精性脂肪肝患者中的应用效果观察[J].中华现代护理杂志，2019，25（15）：1943-1946. |
|
|
|
